KEY
FINDINGS
The global market for hemostatsand sealants is predicted to grow at a CAGR of 8.03% between 2019 and 2027. The
increasing cases of chronic diseases requiring surgeries are primarily driving
the global hemostats and sealants market. The market has been segmented on
the basis of its products into topical hemostat and adhesive &
tissue sealants. The synthetic skin sealants sub-segment, under the adhesive
& tissue sealants category, is flourishing the most in terms of revenues and was valued at $xx million in 2018.
MARKET
INSIGHTS
The predicted rise in global
geriatric population is expected to drive the growth of hemostasis and tissue
sealing market over the forecast period in both the developed economies and emerging
economies like that of India and China. The increasing numbers of minimally-invasive
cosmetic procedures are expected to propel the number of surgeries in the
global healthcare market, which is further expected to propel the market for hemostats
and sealants. Nonetheless, the grafting
of the sealants in the body can cause serious medical complications, resulting
in their increased scrutiny for safety and effectiveness. This can act as a hurdle for the market to
overcome.
REGIONAL INSIGHTS
The
global market for hemostats and tissue sealants is geographically segmented into several
regions, namely, North America, Asia-Pacific, Europe and the countries from the
Rest of the World. North America is expected to capture the largest share of
the global hemostasis and tissue sealing agents market mainly because of the
increasing cases of cardiovascular disorders, diabetes and cancer in this
region. The Asia Pacific market has been projected to grow at a good pace
during the forecast period owing to the better medical tourism and surgical
procedures. The European market is expected to grow due to the upsurge in its geriatric
population, which will result in a higher frequency of surgeries being performed.
- Hemostats and Tissue Sealants Asia Pacific Market: China, India,
Japan, Australia, South Korea & Rest of APAC
- Hemostats and Tissue Sealants Europe Market: The United Kingdom,
France, Germany, Spain, Italy & Rest of Europe
COMPETITIVE
INSIGHTS
Most of the market players
operate through segments that can be involved in discovery, development and
manufacture of healthcare products. Some of these companies are Advanced
Medical Solutions (AMS) Group PLC, Baxter International Inc., B.Braun Melsungen
AG, Cohera Medical Inc., C.R. Bard, Inc., Cryolife Inc., CSL Behring, Hyperbranch
Medical Technology, Inc. (Acquired by Stryker), Integra Lifesciences Corp., Johnson
& Johnson, Medtronic PLC, Pfizer, Inc. and Smith & Nephew PLC.
